CIDRAP-ASP Report – Outcomes Research & AMR: A Human-Centered Perspective on a Biosocial Problem
15 December 2023
In the third of a three-part series, CIDRAP-ASP provides a socioeconomic perspective on AMR outcomes and cost-effectiveness research, advocating for greater consideration of social sciences perspectives, regional diversity and heterogeneity, and systems-based thinking in addressing the societal impacts and costs of AMR.
Further reading: CIDRAP
Author(s): Francesca Chiara and Natalie Vestin
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!